APO treatment of COSphox cells abrogated infection-elicited generation of superoxide (S7 Fig) and significantly attenuated CAB2ΔvopL filamentation (Fig 4C), reducing the number of COSphox cells containing filamentous bacteria by 40% (Fig 4D). The gene discussed is AOPEP; the disease is infection.